Skip to main content

Table 1 Clinical and demographic characteristics of the analyzed sample

From: Association between metabolic syndrome components and gingival bleeding is women-specific: a nested cross-sectional study

Level

Non-exposed

Exposed

p value

n

1129

1129

 

Female (%)

574 (50.8)

574 (50.8)

1.000

Age (%)

   

 < 45 yr

783 (69.4)

783 (69.4)

1.000

 45-65 yr

248 (22.0)

248 (22.0)

 > 65 yr

98 (8.7)

98 (8.7)

Race (%)

   

 Black

319 (28.3)

319 (28.3)

1.000

 Other

31 (2.7)

31 (2.7)

 White

779 (69.0)

779 (69.0)

PIR (mean (SD))

2.86 (1.82)

2.84 (1.83)

0.778

Smokers (%)

561 (49.7)

596 (52.8)

0.152

BMI (%)

   

 Underweight

47 (4.2)

6 (0.5)

 < 0.001

 Normal

766 (67.9)

266 (23.6)

 Overweight

299 (26.5)

434 (38.4)

 Obese

16 (1.4)

423 (37.5)

No. Of MetS factors (%)

   

 0

1129 (100.0)

0 (0.0)

 < 0.001

 1

0 (0.0)

441 (39.1)

 2

0 (0.0)

318 (28.2)

 3

0 (0.0)

206 (18.2)

 4

0 (0.0)

109 (9.7)

 5

0 (0.0)

55 (4.9)

Increased WC (%)

0 (0.0)

628 (55.6)

 < 0.001

High TG (%)

0 (0.0)

429 (38.0)

 < 0.001

Low HDL (%)

0 (0.0)

566 (50.1)

 < 0.001

High BP (%)

0 (0.0)

406 (36.0)

 < 0.001

High glucose (%)

0 (0.0)

377 (33.4)

 < 0.001

Periodontitis (%)

222 (19.7)

259 (22.9)

0.064

Periodontal status (%)

   

 Healthy

705 (62.4)

610 (54.0)

 < 0.001

 Gingivitis

202 (17.9)

260 (23.0)

 Stable periodontitis

143 (12.7)

137 (12.1)

 Active periodontitis

79 (7.0)

122 (10.8)

PISA (mean (SD))

30.36 (61.21)

43.17 (79.81)

 < 0.001

PPD (mean (SD))

2.35 (0.45)

2.43 (0.50)

 < 0.001

CAL (mean (SD))

2.03 (0.91)

2.08 (0.90)

0.220

BoP (mean (SD))

7.44 (12.61)

10.13 (15.06)

 < 0.001

Gingival bleeding (%)

   

 No BoP

596 (52.8)

517 (45.8)

 < 0.001

 BoP < 10%

252 (22.3)

230 (20.4)

 BoP ≥ 10%

281 (24.9)

382 (33.8)

Diabetics (%)

0 (0.0)

74 (6.6)

 < 0.001

Diabetics on insulin (%)

0 (0.0)

19 (28.8)

 < 0.001

SBP (mean (SD))

115.53 (12.76)

124.29 (16.63)

 < 0.001

DBP (mean (SD))

71.83 (8.14)

77.73 (10.25)

 < 0.001

Hypertensives (%)

0 (0.0)

328 (29.2)

 < 0.001

Hypertensives on HT pills (%)

0 (0.0)

158 (76.3)

 < 0.001

BP ≥ 130/80 mmHg

280 (24.8)

570 (50.5)

 < 0.001

BP ≥ 140/90 mmHg

55 (4.9)

239 (21.2)

 < 0.001

HbA1c (%)

   

 Normal

1023 (91.0)

851 (75.7)

 < 0.001

 Pre-diabetes

99 (8.8)

188 (16.7)

 Diabetes

2 (0.2)

85 (7.6)

WBC (mean (SD))

6.72 (2.01)

7.26 (2.20)

 < 0.001

Lymphocytes (mean (SD))

2.16 (0.65)

2.35 (0.90)

 < 0.001

Monocytes (mean (SD))

0.38 (0.18)

0.42 (0.21)

 < 0.001

Granulocytes (mean (SD))

4.18 (1.65)

4.49 (1.77)

 < 0.001

RBC (mean (SD))

4.62 (0.46)

4.73 (0.48)

 < 0.001

Hb (mean (SD))

13.96 (1.41)

14.10 (1.53)

0.021

HTC (mean (SD))

41.42 (3.89)

41.76 (4.15)

0.047

PLT (mean (SD))

262.51 (63.12)

274.01 (72.93)

 < 0.001

Ferritin (mean (SD))

113.32 (119.85)

145.10 (150.36)

 < 0.001

LDL-c (mean (SD))

117.59 (32.28)

129.59 (33.99)

 < 0.001

HDL-c (mean (SD))

60.81 (14.27)

47.27 (14.89)

 < 0.001

CRP (mean (SD))

0.30 (0.43)

0.49 (0.99)

 < 0.001

Glucose (mean (SD))

87.03 (7.18)

101.25 (35.55)

 < 0.001

Creatinine (mean (SD))

1.06 (0.18)

1.07 (0.22)

0.068

Cholesterol (mean (SD))

199.25 (36.22)

210.57 (40.85)

 < 0.001

Triglycerides (mean (SD))

80.67 (27.73)

153.61 (110.03)

 < 0.001

  1. Individuals in the exposed group have at least one MetS component, while non-exposed individuals have none
  2. BMI Body Mass Index, HbA1c glycated hemoglobin, PISA periodontal inflamed surface area, PPD periodontal pocket depth, CAL clinical attachment loss, BoP bleeding on probing, WBC white blood cells, RBC red blood cells, Hb hemoglobin, HCT hematocrit, PLT platelets, LDL-c low density lipoprotein cholesterol, HDL-c high density lipoprotein cholesterol, CRP C-reactive protein, SBP systolic blood pressure, DBP diastolic blood pressure, HT hypertension